Cellular Therapy

Duties and responsibilities: This paper examines the roles and responsibilities of physicians in patients' home countries with respect to patients' decisions to try unproven stem cell therapies abroad. Specifically, it examines professional guidance from two organizations - the American Medical Association and the International Society for Stem Cell Research - and assesses physicians' professional and legal obligations to patients considering unproven stem cell therapies. Then, drawing on qualitative interviews conducted with patients who traveled abroad for unproven stem cell treatments, it explores the roles that physicians actually play in patients' decisions and compares these actual roles with their professional and legal responsibilities. 

Salary: $31,000

Education: Hematopoietic Progenitor Cells (HPC), defined as self-renewing and/or multi-potent stem cells capable of maturation into any of the hematopoietic lineages, lineage-restricted pluri-potent progenitor cells, and committed progenitor cells, regardless of tissue source (bone marrow, umbilical cord blood, peripheral blood, or other tissue source). This includes processing with both minimal and more than minimal manipulation, such as removal or enrichment of various cell populations, expansion of hematopoietic cell populations, and cryopreservation. These Standards apply to administration of HPCs or TCs derived from umbilical cord and/or placental blood but not the collection, processing, or banking of these cells. Standards for these processes are found in the NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration.

Add a picture:

Reflection: I don’t want to be that because I don’t like it.